סך נכסי הפעילות העסקית ACADIA Pharma (ACAD)
ACADIA Pharmaceuticals generates revenue through the sale of patented treatments for psychiatric disorders. This total assets chart clearly demonstrates the issuer's asset base, while 1483.93 captures the current value of the indicator. Exclusive drug rights that protect profits, along with an ethical approach to ecology and medical accessibility in the development of neuropsychiatric drugs, support the business's resilience.
פילוחים אנליטיים של חברת ACADIA Pharmaceuticals Inc (ACAD)
Total assets reflect the aggregate resource potential of ACADIA Pharmaceuticals (ACAD), reverse-calculated via return on assets (ROA) for real-time monitoring of business scale. This total assets chart demonstrates the issuer's financial stability, which is critical given the dependence on a single drug and the risks of generic entries capable of impairing the company's existing asset base.